These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11395543)

  • 1. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy.
    Aronow BJ; Toyokawa T; Canning A; Haghighi K; Delling U; Kranias E; Molkentin JD; Dorn GW
    Physiol Genomics; 2001 Jun; 6(1):19-28. PubMed ID: 11395543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Galphaq.
    Wu G; Toyokawa T; Hahn H; Dorn GW
    J Biol Chem; 2000 Sep; 275(39):29927-30. PubMed ID: 10899155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice.
    Rogers JH; Tsirka A; Kovacs A; Blumer KJ; Dorn GW; Muslin AJ
    J Mol Cell Cardiol; 2001 Feb; 33(2):209-18. PubMed ID: 11162127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galphaq signaling is required for Rho-dependent transcriptional activation of the cyclooxygenase-2 promoter in fibroblasts.
    Slice LW; Han SK; Simon MI
    J Cell Physiol; 2003 Feb; 194(2):127-38. PubMed ID: 12494451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gene expression in transgenic mouse hearts overexpressing calsequestrin.
    Ihara Y; Suzuki YJ; Kitta K; Jones LR; Ikeda T
    Cell Calcium; 2002 Jul; 32(1):21-9. PubMed ID: 12127059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
    Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
    Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation.
    Westenbrink BD; Ling H; Divakaruni AS; Gray CB; Zambon AC; Dalton ND; Peterson KL; Gu Y; Matkovich SJ; Murphy AN; Miyamoto S; Dorn GW; Heller Brown J
    Circ Res; 2015 Feb; 116(5):e28-39. PubMed ID: 25605649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of comparative expression profiling studies of complex diseases: mouse models of myocardial hypertrophy. Focus on "Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy".
    Glueck SB; Dzau VJ; Lee R; Pratt RE
    Physiol Genomics; 2001 Jun; 6(1):1-2. PubMed ID: 11395540
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic factors in cardiac hypertrophy.
    Dorn GW; Hahn HS
    Ann N Y Acad Sci; 2004 May; 1015():225-37. PubMed ID: 15201163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.
    Zhai P; Yamamoto M; Galeotti J; Liu J; Masurekar M; Thaisz J; Irie K; Holle E; Yu X; Kupershmidt S; Roden DM; Wagner T; Yatani A; Vatner DE; Vatner SF; Sadoshima J
    J Clin Invest; 2005 Nov; 115(11):3045-56. PubMed ID: 16276415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy.
    Nebigil CG; Jaffré F; Messaddeq N; Hickel P; Monassier L; Launay JM; Maroteaux L
    Circulation; 2003 Jul; 107(25):3223-9. PubMed ID: 12810613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways.
    Mende U; Kagen A; Cohen A; Aramburu J; Schoen FJ; Neer EJ
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13893-8. PubMed ID: 9811897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    Passier R; Zeng H; Frey N; Naya FJ; Nicol RL; McKinsey TA; Overbeek P; Richardson JA; Grant SR; Olson EN
    J Clin Invest; 2000 May; 105(10):1395-406. PubMed ID: 10811847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase Calpha negatively regulates systolic and diastolic function in pathological hypertrophy.
    Hahn HS; Marreez Y; Odley A; Sterbling A; Yussman MG; Hilty KC; Bodi I; Liggett SB; Schwartz A; Dorn GW
    Circ Res; 2003 Nov; 93(11):1111-9. PubMed ID: 14605019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of exercise-induced cardiac hypertrophy in rats.
    Iemitsu M; Maeda S; Miyauchi T; Matsuda M; Tanaka H
    Acta Physiol Scand; 2005 Dec; 185(4):259-70. PubMed ID: 16266368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy.
    Shi J; Zhang YW; Summers LJ; Dorn GW; Wei L
    J Mol Cell Cardiol; 2008 Mar; 44(3):551-60. PubMed ID: 18178218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype.
    Mende U; Semsarian C; Martins DC; Kagen A; Duffy C; Schoen FJ; Neer EJ
    J Mol Cell Cardiol; 2001 Aug; 33(8):1477-91. PubMed ID: 11448136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse renin gene, TGR(mREN2)27.
    Diedrichs H; Mei C; Frank KF; Boelck B; Schwinger RH
    J Mol Med (Berl); 2004 Oct; 82(10):688-95. PubMed ID: 15322704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy.
    Song Q; Schmidt AG; Hahn HS; Carr AN; Frank B; Pater L; Gerst M; Young K; Hoit BD; McConnell BK; Haghighi K; Seidman CE; Seidman JG; Dorn GW; Kranias EG
    J Clin Invest; 2003 Mar; 111(6):859-67. PubMed ID: 12639992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.